Nervgen Pharma NGEN
NASDAQ NGEN
$1.51 -0.03 (-1.96%)
As of: Oct 21, 2026 · 3:46 PM EDT

Nervgen Pharma (NGEN) Total Current Liabilities (2024 - 2026)

Updated

Nervgen Pharma (NGEN) reported Total Current Liabilities of $52.71 million for the quarter ended Jun 30, 2026, up 374.8% from the prior quarter.

Analysis

Nervgen Pharma (NGEN) Total Current Liabilities (2024 - 2026) Analysis & Trends

As of Dec 31, 2025, Nervgen Pharma posted Total Current Liabilities of $14.12 million, up 14.4% from the prior year.

  • By year, Total Current Liabilities came in at $12.34 million in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Eli Lilly 1,138.83 Bn 1,107.41 Bn 19.71 Bn 47.74 Bn
2 Johnson & Johnson 618.88 Bn 537.41 Bn 17.26 Bn 54.90 Bn
3 AbbVie 502.93 Bn 476.04 Bn 12.70 Bn 41.64 Bn
4 Merck 369.61 Bn 323.99 Bn 12.21 Bn 27.73 Bn
5 Novartis Ag 298.70 Bn 262.69 Bn 11.24 Bn 31.75 Bn
6 Astrazeneca 261.35 Bn 235.03 Bn 12.86 Bn 31.55 Bn
7 Amgen 237.59 Bn 192.99 Bn 7.24 Bn 25.50 Bn
8 Gilead Sciences 191.60 Bn 165.79 Bn 6.22 Bn 11.02 Bn
9 Pfizer 170.23 Bn 116.88 Bn 10.94 Bn 32.65 Bn
10 Nervgen Pharma 109.22 Mn 8.10 Mn - 51.32 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 51.32 Mn
Mar 31, 2026 10.93 Mn
Dec 31, 2025 14.41 Mn
Dec 31, 2024 11.78 Mn
API Access

Nervgen Pharma Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=NGEN&period=max&api_key=YOUR_API_KEY